Daha iyi bir deneyim için konum izni vermelisiniz.
MENU
ÖZGEÇMİŞ
BİLİMSEL YAYINLAR
EĞİTİM
  • 2013 Uludağ Üniversitesi / Farmakoloji / Doktora
  • 2001 Uludağ Üniversitesi Tıp Fakültesi Tıbbi Onkoloji
  • 2000 Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları
  • 1995 Ondokuzmayıs Üniversitesi Tıp Fakültesi
İŞ DENEYİMİ
  • 2019 - Halen Acıbadem Sağlık Grubu
  • 2012 Vall d''Hebron Institute of Oncology Gastrointestinal and Phase I units / Barselona (Prof. Joseph Tabernero ile birlikte)
  • 2011 - 2011 Fox Chase Cancer Center Philadelphia Externship Organization
  • 2011 - 2011 The University of North Carolina at Chapel Hill Cancer Hospital / Gastrointestinal Cancer Unit (Prof. Bert O?Neil ve Prof. Richard Goldberg ile birlikte)
  • 2011 - 2011 Memorial Sloan Kettering Cancer Center / Gastrointestinal Cancer Unit (Prof. Nancy Kemeny ile birlikte) / New York, Amerika Birleşik Devletleri
  • 1995 - 2019 Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları ABD / Tıbbi Onkoloji Bilim Dalı
BİLİMSEL YAYINLAR
  • Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status World J Clin Cases. 2018 Oct 6;6(11):418-425. doi: 10.12998/wjcc.v6.i11.418. Review. Kanat O, Ertas H, Caner B.
  • Shattering the castle walls: Anti-stromal therapy for pancreatic cancer World J Gastrointest Oncol. 2018 Aug 15;10(8):202-210. doi: 10.4251/wjgo.v10.i8.202. Review. Kanat O, Ertas H.
  • Platinum-induced neurotoxicity: A review of possible mechanisms World J Clin Oncol. 2017 Aug 10;8(4):329-335. doi: 10.5306/wjco.v8.i4.329. Review. Kanat O, Ertas H, Caner B.
  • Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma : implications for clinicopathology and patient outcomes Acta Gastroenterol Belg. 2017 Jan-Mar;80(1):31-37. Uğraş N, Yerci Ö, Özgün G, Deligönül A, Dündar HZ, Sarkut P, Kanat Ö.
  • Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer J BUON. 2016 May-Jun;21(3):564-9 Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, Hartavi M, Fatih Olmez O, Kurt E, Tolunay S, Kanat O, Manavoglu O.
  • Current treatment options for patients with initially unresectable isolated colorectal liver metastases World J Clin Oncol. 2016 Feb 10;7(1):9-14. doi: 10.5306/wjco.v7.i1.9. Kanat O.
  • Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients Asian Pac J Cancer Prev. 2016;17(3):1175-9. Gorukmez O, Yakut T, Gorukmez O, Sag SO, Karkucak M, Kanat O.
  • Targeted therapy for advanced gastric cancer: A review of current status and future prospects World J Gastrointest Oncol. 2015 Dec 15;7(12):401-10. doi: 10.4251/wjgo.v7.i12.401. Review. Kanat O, O''Neil B, Shahda S.
  • linical significance of adiponectin expression in colon cancer patients J Cancer Res Ther. 2014 Apr-Jun;10(2):347-53. doi: 10.4103/0973-1482.136634. Canhoroz M, Kanat O, Saraydaroglu O, Buluc E, Avci N, Cubukcu E, Olmez OF, Manavoglu O.
  • Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454. Epub 2014 Feb 28. Cubukcu E, Olmez OF, Kanat O, Kabul S, Canhoroz M, Avci N, Hartavi M, Deligonul A, Cubukçu S, Manavoglu O.
Size nasıl yardımcı olabiliriz?